NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
Holders of 5% or more of NPCE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of NeuroPace Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Light Asset Management, LLC | 13G/A | 12.25%4.20M shares | +3.58 ppfrom 8.67% | May 15, 20262 filings | Sep 4, 2026 | SEC |
| Polar Capital Holdings Plc | 13G | 9.13%2.97M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
| Soleus Private Equity Fund I, L.P. | 13G/A | 8.90%2.96M shares | – | Nov 7, 20251 filing | Nov 7, 2025 | SEC |
| Morgan Stanley | 13G/A | 8.30%2.49M shares | – | Feb 4, 20251 filing | Feb 4, 2025 | SEC |
| Soleus Capital Master Fund, L.P. | 13G/A | 7.00%2.30M shares | – | Aug 5, 20251 filing | Aug 5, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on NeuroPace Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 20264:45 PM ET | First Light Asset Management, LLCand 1 other | 13G/A | 12.25%4.20M shares | +3.58 ppfrom 8.67% | Aug 31, 2026 | SEC |
| Aug 14, 20265:40 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 4.40%1.51M shares | −1.80 ppfrom 6.20%Below 5% | Jun 30, 2026 | SEC |
| May 15, 20264:41 PM ET | First Light Asset Management, LLCand 1 other | 13G | 8.67%2.96M shares | New | Mar 31, 2026 | SEC |
| May 15, 20264:35 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 6.20%2.10M shares | −1.80 ppfrom 8.00% | Mar 31, 2026 | SEC |
| Nov 7, 20254:00 PM ET | Soleus Private Equity Fund I, L.P.and 8 others | 13G/A | 8.90%2.96M shares | – | Sep 30, 2025 | SEC |
| Sep 3, 20254:48 PM ET | KCK Ltd. | 13G/A | 0.00%0 shares | −17.70 ppfrom 17.70%Below 5% | Feb 20, 2025 | SEC |
| Aug 14, 20256:03 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 8.00%2.61M shares | −2.50 ppfrom 10.50% | Jun 30, 2025 | SEC |
| Aug 5, 20255:00 PM ET | Soleus Capital Master Fund, L.P.and 8 others | 13G/A | 7.00%2.30M shares | – | Jun 30, 2025 | SEC |
| May 15, 20258:15 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 10.50%3.41M shares | – | Mar 31, 2025 | SEC |
| May 15, 202510:21 AM ET | Polar Capital Holdings Plcand 1 other | 13G | 9.13%2.97M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20252:07 PM ET | Kent Lake PR LLCand 2 others | 13G/A | 4.90%1.48M shares | −0.10 ppfrom 5.00%Below 5% | Dec 31, 2024 | SEC |
| Feb 11, 20254:38 PM ET | KCK Ltd. | 13G/A | 17.70%5.27M shares | – | Dec 31, 2024 | SEC |
| Feb 4, 202512:50 PM ET | Morgan Stanleyand 1 other | 13G/A | 8.30%2.49M shares | – | Dec 31, 2024 | SEC |
| Nov 4, 20244:51 PM ET | Kent Lake PR LLCand 2 others | 13G | 5.00%1.47M shares | New | Oct 25, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell NeuroPace Inc shares.
No Form 144 notices for NeuroPace Inc are on file.